- Home
- NOG vs SUPN Comparison
NOG vs SUPN Comparison
Compare NOG & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOG
- SUPN
- Stock Information
- Founded
- NOG 2006
- SUPN 2005
- Country
- NOG United States
- SUPN United States
- Employees
- NOG N/A
- SUPN N/A
- Industry
- NOG Oil & Gas Production
- SUPN Biotechnology: Pharmaceutical Preparations
- Sector
- NOG Energy
- SUPN Health Care
- Exchange
- NOG Nasdaq
- SUPN Nasdaq
- Market Cap
- NOG 2.6B
- SUPN 2.6B
- IPO Year
- NOG N/A
- SUPN 2012
- Fundamental
- Price
- NOG $24.77
- SUPN $47.92
- Analyst Decision
- NOG Buy
- SUPN Buy
- Analyst Count
- NOG 8
- SUPN 2
- Target Price
- NOG $31.14
- SUPN $51.50
- AVG Volume (30 Days)
- NOG 2.1M
- SUPN 682.2K
- Earning Date
- NOG 11-04-2025
- SUPN 11-03-2025
- Dividend Yield
- NOG 7.24%
- SUPN N/A
- EPS Growth
- NOG 6.84
- SUPN 1411.53
- EPS
- NOG 6.08
- SUPN 1.14
- Revenue
- NOG $2,094,039,000.00
- SUPN $665,125,000.00
- Revenue This Year
- NOG $18.65
- SUPN $6.71
- Revenue Next Year
- NOG N/A
- SUPN $19.74
- P/E Ratio
- NOG $4.09
- SUPN $42.23
- Revenue Growth
- NOG 6.25
- SUPN 5.55
- 52 Week Low
- NOG $19.88
- SUPN $29.16
- 52 Week High
- NOG $44.31
- SUPN $49.66
- Technical
- Relative Strength Index (RSI)
- NOG 45.56
- SUPN 66.02
- Support Level
- NOG $24.04
- SUPN $47.34
- Resistance Level
- NOG $25.90
- SUPN $49.66
- Average True Range (ATR)
- NOG 0.95
- SUPN 1.23
- MACD
- NOG -0.11
- SUPN -0.08
- Stochastic Oscillator
- NOG 20.49
- SUPN 66.70
About NOG Northern Oil and Gas Inc.
Northern Oil & Gas Inc is an independent energy company engaged in the acquisition, exploration, development, and production of crude oil and natural gas properties. Its principal business is crude oil and natural gas exploration, development, and production. The company's oil and natural gas sales come from three geographic areas in the United States: the Williston Basin (North Dakota and Montana), the Permian Basin (New Mexico and Texas), the Uinta Basin, and the Appalachian Basin (Pennsylvania and Ohio).
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.